Home › Companies › Alnylam Pharmaceuticals, Inc.
How asset managers voted at Alnylam Pharmaceuticals, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Alnylam Pharmaceuticals, Inc. | 5 | 680 |
| 2024-2025 | Alnylam Pharmaceuticals, Inc. | 8 | 589 |
| 2023-2024 | ALNYLAM PHARMACEUTICALS INC. | 6 | 480 |
Earlier seasons list this company under the name ALNYLAM PHARMACEUTICALS INC., as its holders filed it.
Explore Alnylam Pharmaceuticals, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on October 25, 2026. This page is rebuilt weekly; built October 26, 2026.